You are here
Clinical Trials: Lung Disease
Discuss
Each Clinical Trial will open in a new browser window or tab.
Condition: Bronchopulmonary Dysplasia
Interventions: Drug: Human Umbilical Cord-derived Mesenchymal stem cell; Drug: placebo
Sponsor: Children's Hospital of Fudan University
Not yet recruiting
Interventions: Drug: Human Umbilical Cord-derived Mesenchymal stem cell; Drug: placebo
Sponsor: Children's Hospital of Fudan University
Not yet recruiting
Condition: Bronchopulmonary Dysplasia
Intervention: Biological: Human Umbilical Cord Derived-Mesenchymal Stem Cells
Sponsor: Meridigen Biotech Co., Ltd.
Not yet recruiting
Intervention: Biological: Human Umbilical Cord Derived-Mesenchymal Stem Cells
Sponsor: Meridigen Biotech Co., Ltd.
Not yet recruiting
Condition: Refractory Pulmonary Diseases
Interventions: Drug: Transplantation of mesenchymal stem cell; Drug: No Transplantation of Mesenchymal Stem Cell
Sponsor: Children's Hospital of Chongqing Medical University
Recruiting
Interventions: Drug: Transplantation of mesenchymal stem cell; Drug: No Transplantation of Mesenchymal Stem Cell
Sponsor: Children's Hospital of Chongqing Medical University
Recruiting
Condition: Bronchopulmonary Dysplasia
Interventions: Drug: Transplantation of mesenchymal stem cell; Drug: No transplantation of mesenchymal stem cell
Sponsor: Children's Hospital of Chongqing Medical University
Recruiting
Interventions: Drug: Transplantation of mesenchymal stem cell; Drug: No transplantation of mesenchymal stem cell
Sponsor: Children's Hospital of Chongqing Medical University
Recruiting
Conditions: Acute Respiratory Distress Syndrome (ARDS); Multiple Organ Failure
Intervention: Biological: MSC
Sponsor: Fujian Medical University
Not yet recruiting
Intervention: Biological: MSC
Sponsor: Fujian Medical University
Not yet recruiting
Condition: Pulmonary Arterial Hypertension
Intervention: Behavioral: Endurance training
Sponsor: Hospital Clinic of Barcelona
Recruiting
Intervention: Behavioral: Endurance training
Sponsor: Hospital Clinic of Barcelona
Recruiting
Condition: Severe Bronchopulmonary Dysplasia
Interventions: Biological: PNEUMOSTEM; Other: Placebo
Sponsor: Medipost Co Ltd.
Not yet recruiting
Interventions: Biological: PNEUMOSTEM; Other: Placebo
Sponsor: Medipost Co Ltd.
Not yet recruiting
Condition: Bronchopulmonary Dysplasia
Interventions: Drug: transplantation of mesenchymal stem cell; Drug: no transplantation of mesenchymal stem cell
Sponsors: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University; Children's Hospital of Chongqing Medical University; Chongqing Maternal and Child Health Hospital
Recruiting
Interventions: Drug: transplantation of mesenchymal stem cell; Drug: no transplantation of mesenchymal stem cell
Sponsors: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University; Children's Hospital of Chongqing Medical University; Chongqing Maternal and Child Health Hospital
Recruiting
Condition: Bacterial Pneumonia
Intervention: Drug: Cx611 or Placebo
Sponsors: TiGenix S.A.U.; European Commission; Centre Hospital Regional Universitaire de Limoges; Cliniques universitaires Saint-Luc- Université Catholique de Louvain; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Hospital San Carlos, Madrid
Recruiting - verified May 2017
Intervention: Drug: Cx611 or Placebo
Sponsors: TiGenix S.A.U.; European Commission; Centre Hospital Regional Universitaire de Limoges; Cliniques universitaires Saint-Luc- Université Catholique de Louvain; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); Hospital San Carlos, Madrid
Recruiting - verified May 2017
Condition: Pulmonary Arterial Hypertension (PAH)
Interventions: Biological: Allogeneic Human Cardiosphere-Derived Stem Cells; Biological: Placebo
Sponsors: Cedars-Sinai Medical Center; California Institute for Regenerative Medicine
Not yet recruiting - verified May 2017
Interventions: Biological: Allogeneic Human Cardiosphere-Derived Stem Cells; Biological: Placebo
Sponsors: Cedars-Sinai Medical Center; California Institute for Regenerative Medicine
Not yet recruiting - verified May 2017
